Company

Exo Therapeutics

Biotechnology Research 150 Cambridge Park Dr 18 employees

Employees: 18
Contacts: 3
Emails: 3
Phones: 1

Exo Therapeutics Overview

Headquarters: 150 Cambridge Park Dr
Industry: Biotechnology Research
Employees: 18
Founded: 2018
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

Keywords

Manager jobs

About Exo Therapeutics

Exo Therapeutics is a small molecule drug discovery and development company with a pioneering technology to address intractable pharmaceutical targets. By leveraging the company’s ExoSightTM platform, Exo is developing a deep pipeline of potent drug candidates that bind exosites, distal and unique binding pockets that have the potential to reprogram enzyme activity for precise and robust therapeutic effect. Through this specific and selective approach to challenging targets, the company’s team of world-class researchers is unlocking breakthrough therapeutics in oncology, inflammation and a broad range of other diseases.

Exo Therapeutics Contact Details

People in AeroLeads: 4
With contact data: 3
Email contacts: 3; 75.0% coverage
Phone contacts: 1; 25.0% coverage

Exo Therapeutics Org Chart

Sample employees and titles

Name	Title	Location	Contact
Kevin Leach, Ph.d, Dabt		Lexington, Massachusetts, United States	Email Phone
James Edwards	Venture Partner, Samsara Biocapital	San Diego, California, United States	Email
Hui Liu	Associate Principal Scientist at Astrazeneca	Boston, Massachusetts, United States	Email
Tom M. Thomas, Ph.d.	Investor @ Newpath Partners		View